Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simone M Goldinger

Showing results (11-20 of 69) with videos related to

Pageof 7
Sort By:
Cancers|November 13, 2025
The Impact of Multidisciplinary Research on Progress in Skin Cancer PreventionAlyssa Susanto, Clare Primiero, Simone M Goldinger, et al.
The Journal of Investigative Dermatology|April 16, 2014
To B-(RAF) or not to beReinhard Dummer, Simone M Goldinger, Daniel Widmer, et al.
European Journal of Dermatology : EJD|March 20, 2015
Clinical observation of panniculitis in two patients with BRAF-mutated metastatic melanoma treated with a combination of a BRAF inhibitor and a MEK inhibitorNadja A Galliker, Carla Murer, Jivko Kamarashev, et al.
Current Opinion in Oncology|December 28, 2016
Critical aspects to achieve a high-quality melanoma clinicReinhard Dummer, Egle Ramelyte, Mitch Levesque, et al.
Melanoma Research|April 15, 2017
Successful treatment with imatinib after nilotinib and ipilimumab in a c-kit-mutated advanced melanoma patient: a case reportCarla Murer, Pascale Kränzlin-Stieger, Lars E French, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 20, 2026
Evolving landscape of consumer-based smartphone apps for skin cancer prevention and early detectionNurul Amanina Binte Hussain, Abigail King, Caitlin Horsham, et al.
Experimental Dermatology|November 16, 2023
Epidermal growth factor receptor inhibitors in advanced cutaneous squamous cell carcinoma: A systematic review and meta-analysisJames P Pham, Anthony Rodrigues, Simone M Goldinger, et al.
The Journal of Investigative Dermatology|December 14, 2011
Cutaneous lymphomas: molecular pathways leading to new drugsReinhard Dummer, Simone M Goldinger, Antonio Cozzio, et al.
The Oncologist|September 4, 2020
Long-Term Response to Intermittent Binimetinib in Patients with NRAS-Mutant MelanomaAlexandra Valeska Matter, Sara Micaletto, Ursula Urner-Bloch, et al.
Current Oncology Reports|March 29, 2023
Chemotherapy in Cutaneous Melanoma: Is There Still a Role?James P Pham, Anthony M Joshua, Ines P da Silva, et al.
Pageof 7

Showing results (11-20 of 69) with videos related to

Sort By:
Pageof 7
Cancers|November 13, 2025
The Impact of Multidisciplinary Research on Progress in Skin Cancer PreventionAlyssa Susanto, Clare Primiero, Simone M Goldinger, et al.
The Journal of Investigative Dermatology|April 16, 2014
To B-(RAF) or not to beReinhard Dummer, Simone M Goldinger, Daniel Widmer, et al.
European Journal of Dermatology : EJD|March 20, 2015
Clinical observation of panniculitis in two patients with BRAF-mutated metastatic melanoma treated with a combination of a BRAF inhibitor and a MEK inhibitorNadja A Galliker, Carla Murer, Jivko Kamarashev, et al.
Current Opinion in Oncology|December 28, 2016
Critical aspects to achieve a high-quality melanoma clinicReinhard Dummer, Egle Ramelyte, Mitch Levesque, et al.
Melanoma Research|April 15, 2017
Successful treatment with imatinib after nilotinib and ipilimumab in a c-kit-mutated advanced melanoma patient: a case reportCarla Murer, Pascale Kränzlin-Stieger, Lars E French, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 20, 2026
Evolving landscape of consumer-based smartphone apps for skin cancer prevention and early detectionNurul Amanina Binte Hussain, Abigail King, Caitlin Horsham, et al.
Experimental Dermatology|November 16, 2023
Epidermal growth factor receptor inhibitors in advanced cutaneous squamous cell carcinoma: A systematic review and meta-analysisJames P Pham, Anthony Rodrigues, Simone M Goldinger, et al.
The Journal of Investigative Dermatology|December 14, 2011
Cutaneous lymphomas: molecular pathways leading to new drugsReinhard Dummer, Simone M Goldinger, Antonio Cozzio, et al.
The Oncologist|September 4, 2020
Long-Term Response to Intermittent Binimetinib in Patients with NRAS-Mutant MelanomaAlexandra Valeska Matter, Sara Micaletto, Ursula Urner-Bloch, et al.
Current Oncology Reports|March 29, 2023
Chemotherapy in Cutaneous Melanoma: Is There Still a Role?James P Pham, Anthony M Joshua, Ines P da Silva, et al.
Pageof 7